An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

Полное описание

Библиографические подробности
Главные авторы:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
Формат:	Journal article
Язык:	English
Опубликовано:	1998

Схожие документы

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
по: Cerundolo, V, и др.
Опубликовано: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
по: Kelleher, A, и др.
Опубликовано: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
по: Gileadi, U, и др.
Опубликовано: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
по: Klenerman, P, и др.
Опубликовано: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
по: Anjali K. Gupta, и др.
Опубликовано: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
по: Milicic, A, и др.
Опубликовано: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
по: Atul Pawar, и др.
Опубликовано: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
по: Valmori, D, и др.
Опубликовано: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
по: Sham, Hoi Fung
Опубликовано: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
по: Cerundolo, V, и др.
Опубликовано: (1997)

Current and Novel Inhibitors of HIV Protease
по: Jan Konvalinka, и др.
Опубликовано: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
по: Johanna Bialas, и др.
Опубликовано: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
по: Kourjian G, и др.
Опубликовано: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
по: Jorissen, Robert N., и др.
Опубликовано: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
по: V.B. Denisenko, и др.
Опубликовано: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
по: V.B. Denisenko, и др.
Опубликовано: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
по: Murray, R, и др.
Опубликовано: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
по: Valmori, D, и др.
Опубликовано: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
по: Gupta, A, и др.
Опубликовано: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
по: Larissa da Costa Souza, и др.
Опубликовано: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
по: S. V. Semochkin
Опубликовано: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
по: Romério Rodrigues dos Santos Silva, и др.
Опубликовано: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
по: Fabrizio Mammano, и др.
Опубликовано: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
по: Roberta Rinaldi, и др.
Опубликовано: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
по: Abhilash I. Chiramel, и др.
Опубликовано: (2019-06-01)

Site-Specific Proteasome Inhibitors
по: Alexei F. Kisselev
Опубликовано: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
по: Noah M. Merin, и др.
Опубликовано: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
по: Christoph Driessen, и др.
Опубликовано: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
по: Hemelaar, J, и др.
Опубликовано: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
по: Nathalie Vigneron, и др.
Опубликовано: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
по: Tran Linh, и др.
Опубликовано: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
по: Chougrani I, и др.
Опубликовано: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
по: Kathleen M S E Reyskens, и др.
Опубликовано: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
по: Konvalinka Jan, и др.
Опубликовано: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
по: Kann G, и др.
Опубликовано: (2021-08-01)

Immune surveillance and AIDS progression.
по: Zinkernagel, R, и др.
Опубликовано: (1997)

Correspondence - Immune surveillance and AIDS progression
по: Zinkernagel, R, и др.
Опубликовано: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
по: Klenerman, P, и др.
Опубликовано: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
по: Klenerman, P, и др.
Опубликовано: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
по: J. Lopes, и др.
Опубликовано: (2021-04-01)